Skip to main content
Premium Trial:

Request an Annual Quote

Wyeth Research Expands PGx Contract with Expression Analysis

NEW YORK, March 1 (GenomeWeb News) - Wyeth and Expression Analysis have expanded their July 2004 pharmacogenomics testing services agreement, Expression Analysis said yesterday.

 

The microarray services will use the Affymetrix GeneChip platform and will be compliant with 21 CFR Part 58, the company said in a statement.

 

Financial details were not provided.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.